Corticostriatal plastic changes in experimental L-DOPA-induced dyskinesia

Parkinson's Disease

Volumn , Issue , 2012, Pages

  Ghiglieri, Veronica ^a   Bagetta, Vincenza ^a   Pendolino, Valentina ^a   Picconi, Barbara ^a   Calabresi, Paolo ^a,b  

^a IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMPA RECEPTOR; DOPAMINE; DOPAMINE RECEPTOR; GLUTAMATE RECEPTOR; LEVODOPA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PHOSPHODIESTERASE INHIBITOR; SEROTONIN;

BASAL GANGLION; CHOLINERGIC NERVE CELL; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; DOPAMINERGIC TRANSMISSION; DRUG INDUCED DISEASE; DYSKINESIA; INTERNEURON; LEVODOPA INDUCED DYSKINESIA; LONG TERM DEPRESSION; NERVE CELL PLASTICITY; NERVE DEGENERATION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RECEPTOR BINDING; REVIEW; SEROTONINERGIC NERVE CELL; SEROTONINERGIC SYSTEM;

EID: 84862279396     PISSN: None     EISSN: 20420080     Source Type: Journal    
DOI: 10.1155/2012/358176     Document Type: Review

References (94)

1. Paillé V., Picconi B., Bagetta V., Ghiglieri V., Sgobio C., Di Filippo M., Viscomi M. T., Giamp C., Fusco F. R., Gardoni F., Bernardi G., Greengard P., Di Luca M., Calabresi P., Distinct levels of dopamine denervation differentially alter striatal synaptic plasticity and NMDA receptor subunit composition Journal of Neuroscience 2010 30 42 14182 14193
2. Picconi B., Centonze D., Hkansson K., Bernardi G., Greengard P., Fisone G., Cenci M. A., Calabresi P., Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia Nature Neuroscience 2003 6 5 501 506 (Pubitemid 36514698)
3. Calabresi P., Filippo M. D., Ghiglieri V., Tambasco N., Picconi B., Levodopa-induced dyskinesias in patients with Parkinson's disease: filling the bench-to-bedside gap The Lancet Neurology 2010 9 11 1106 1117
4. Morgante F., Espay A. J., Gunraj C., Lang A. E., Chen R., Motor cortex plasticity in Parkinson's disease and levodopa-induced dyskinesias Brain 2006 129 4 1059 1069
5. Prescott I. A., Dostrovsky J. O., Moro E., Hodaie M., Lozano A. M., Hutchison W. D., Levodopa enhances synaptic plasticity in the substantia nigra pars reticulata of Parkinson's disease patients Brain 2009 132 2 309 318
6. Lovinger D. M., Tyler E. C., Merritt A., Short- and long-term synaptic depression in rat neostriatum Journal of Neurophysiology 1993 70 5 1937 1949 (Pubitemid 23351034)
7. Calabresi P., Maj R., Pisani A., Mercuri N. B., Bernardi G., Long-term synaptic depression in the striatum: physiological and pharmacological characterization Journal of Neuroscience 1992 12 11 4224 4233
8. Calabresi P., Pisani A., Mercuri N. B., Bernardi G., Long-term potentiation in the striatum is unmasked by removing the voltage-dependent magnesium block of NMDA receptor channels European Journal of Neuroscience 1992 4 10 929 935
9. Calabresi P., Picconi B., Tozzi A., Di Filippo M., Dopamine-mediated regulation of corticostriatal synaptic plasticity Trends in Neurosciences 2007 30 5 211 219 (Pubitemid 46654232)
10. Calabresi P., Centonze D., Bernardi G., Electrophysiology of dopamine in normal and denervated striatal neurons Trends in Neurosciences 2000 23 10, supplement 1 S57 S63
11. Calabresi P., Maj R., Mercuri N. B., Bernardi G., Coactivation of D1 and D2 dopamine receptors is required for long-term synaptic depression in the striatum Neuroscience Letters 1992 142 1 95 99
12. Bagetta V., Ghiglieri V., Sgobio C., Calabresi P., Picconi B., Synaptic dysfunction in Parkinson's disease Biochemical Society Transactions 2010 38 2 493 497
13. Centonze D., Gubellini P., Bernardi G., Calabresi P., Permissive role of interneurons in corticostriatal synaptic plasticity Brain Research Reviews 1999 31 1 1 5 (Pubitemid 30009610)
14. Picconi B., Gardoni F., Centonze D., Mauceri D., Cenci M. A., Bernardi G., Calabresi P., Di Luca M., Abnormal Ca 2+ -calmodulin-dependent protein kinase II function mediates synaptic and motor deficits in experimental parkinsonism Journal of Neuroscience 2004 24 23 5283 5291 (Pubitemid 38747668)
15. O'Dell T. J., Kandel E. R., Low-frequency stimulation erases LTP through an NMDA receptor-mediated activation of protein phosphatases Learning Memory 1994 1 2 129 139 (Pubitemid 2143750)
16. Gardoni F., Picconi B., Ghiglieri V., Polli F., Bagetta V., Bernardi G., Cattabeni F., Di Luca M., Calabresi P., A critical interaction between NR2B and MAGUK in L-DOPA induced dyskinesia Journal of Neuroscience 2006 26 11 2914 2922
17. Picconi B., Passino E., Sgobio C., Bonsi P., Barone I., Ghiglieri V., Pisani A., Bernardi G., Ammassari-Teule M., Calabresi P., Plastic and behavioral abnormalities in experimental Huntington's disease: a crucial role for cholinergic interneurons Neurobiology of Disease 2006 22 1 143 152
18. Borgkvist A., Fisone G., Psychoactive drugs and regulation of the cAMP/PKA/DARPP-32 cascade in striatal medium spiny neurons Neuroscience and Biobehavioral Reviews 2007 31 1 79 88 (Pubitemid 44880073)
19. Fienberg A. A., Hiroi N., Mermelstein P. G., Song W. J., Snyder G. L., Nishi A., Cheramy A., O'Callaghan J. P., Miller D. B., Cole D. G., Corbett R., Haile C. N., Cooper D. C., Onn S. P., Grace A. A., Ouimet C. C., White F. J., Hyman S. E., Surmeier D. J., Girault J. A., Nestler E. J., Greengard P., DARPP-32: regulator of the efficacy of dopaminergic neurotransmission Science 1998 281 5378 838 842 (Pubitemid 28376047)
20. Greengard P., The neurobiology of dopamine signaling Bioscience Reports 2001 21 3 247 269 (Pubitemid 34208249)
21. Gardoni F., Ghiglieri V., Luca M. D., Calabresi P., Assemblies of glutamate receptor subunits with post-synaptic density proteins and their alterations in Parkinson's disease Progress in Brain Research 2010 183 C 169 182
22. Fiorentini C., Gardoni F., Spano P., Di Luca M., Missale C., Regulation of dopamine D1 receptor trafficking and desensitization by oligomerization with glutamate N -methyl-D-aspartate receptors Journal of Biological Chemistry 2003 278 22 20196 20202 (Pubitemid 36799216)
23. Fiorentini C., Rizzetti M. C., Busi C., Bontempi S., Collo G., Spano P., Missale C., Loss of synaptic D1 dopamine/ N -methyl-D-aspartate glutamate receptor complexes in L-DOPA-induced dyskinesia in the rat Molecular Pharmacology 2006 69 3 805 812 (Pubitemid 43363855)
24. Hallett P. J., Spoelgen R., Hyman B. T., Standaert D. G., Dunah A. W., Dopamine D1 activation potentiates striatal NMDA receptors by tyrosine phosphorylation-dependent subunit trafficking Journal of Neuroscience 2006 26 17 4690 4700 (Pubitemid 44315370)
25. Cepeda C., Buchwald N. A., Levine M. S., Neuromodulatory actions of dopamine in the neostriatum are dependent upon the excitatory amino acid receptor subtypes activated Proceedings of the National Academy of Sciences of the United States of America 1993 90 20 9576 9580 (Pubitemid 23315828)
26. Snyder G. L., Fienberg A. A., Huganir R. L., Greengard P., A dopamine/D1 receptor/protein kinase A/dopamine- and cAMP-regulated phosphoprotein (Mr 32 kDa)/protein phosphatase-1 pathway regulates dephosphorylation of the NMDA receptor Journal of Neuroscience 1998 18 24 10297 10303 (Pubitemid 29016549)
27. Sun X., Zhao Y., Wolf M. E., Dopamine receptor stimulation modulates AMPA receptor synaptic insertion in prefrontal cortex neurons Journal of Neuroscience 2005 25 32 7342 7351 (Pubitemid 41129806)
28. Gao C., Sun X., Wolf M. E., Activation of D1 dopamine receptors increases surface expression of AMPA receptors and facilitates their synaptic incorporation in cultured hippocampal neurons Journal of Neurochemistry 2006 98 5 1664 1677 (Pubitemid 44200455)
29. Gubellini P., Pisani A., Centonze D., Bernardi G., Calabresi P., Metabotropic glutamate receptors and striatal synaptic plasticity: implications for neurological diseases Progress in Neurobiology 2004 74 5 271 300 (Pubitemid 39586720)
30. Kawaguchi Y., Physiological, morphological, and histochemical characterization of three classes of interneurons in rat neostriatum Journal of Neuroscience 1993 13 11 4908 4923 (Pubitemid 23326358)
31. Kawaguchi Y., Wilson C. J., Augood S. J., Emson P. C., Striatal interneurones: chemical, physiological and morphological characterization Trends in Neurosciences 1995 18 12 527 535
32. Centonze D., Gubellini P., Pisani A., Bernardi G., Calabresi P., Dopamine, acetylcholine, and nitric oxide systems interact to induce corticostriatal synaptic plasticity Reviews in the Neurosciences 2003 14 3 207 216 (Pubitemid 37237191)
33. Suzuki T., Miura M., Nishimura K. Y., Aosaki T., Dopamine-dependent synaptic plasticity in the striatal cholinergic interneurons Journal of Neuroscience 2001 21 17 6492 6501 (Pubitemid 32781093)
34. Calabresi P., Centonze D., Gubellini P., Pisani A., Bernardi G., Acetylcholine-mediated modulation of striatal function Trends in Neurosciences 2000 23 3 120 126 (Pubitemid 30112539)
35. Fino E., Deniau J. M., Venance L., Cell-specific spike-timing-dependent plasticity in GABAergic and cholinergic interneurons in corticostriatal rat brain slices Journal of Physiology 2008 586 1 265 282
36. Tozzi A., De Iure A., Di Filippo M., Tantucci M., Costa C., Borsini F., Ghiglieri V., Giamp C., Fusco F. R., Picconi B., Calabresi P., The distinct role of medium spiny neurons and cholinergic interneurons in the D2/A2A receptor interaction in the striatum: implications for Parkinson's disease Journal of Neuroscience 2011 31 5 1850 1862
37. Augood S. J., McGowan E. M., Emson P. C., Expression of N -methyl-D-aspartate receptor subunit NR1 messenger RNA by identified striatal somatostatin cells Neuroscience 1994 59 1 7 12 (Pubitemid 24125027)
38. Catania M. V., Tlle T. R., Monyer H., Differential expression of AMPA receptor subunits in NOS-positive neurons of cortex, striatum, and hippocampus Journal of Neuroscience 1995 15 11 7046 7061
39. Marin P., Lafon-Cazal M., Bockaert J., A nitric oxide synthase activity selectively stimulated by NMDA receptors depends on protein kinase C activation in mouse striatal neurons European Journal of Neuroscience 1992 4 5 425 432
40. Weiss S. W., Albers D. S., Iadarola M. J., Dawson T. M., Dawson V. L., Standaert D. G., NMDAR1 glutamate receptor subunit isoforms in neostriatal, neocortical, and hippocampal nitric oxide synthase neurons Journal of Neuroscience 1998 18 5 1725 1734 (Pubitemid 28103080)
41. Prast H., Philippu A., Nitric oxide as modulator of neuronal function Progress in Neurobiology 2001 64 1 51 68 (Pubitemid 32201889)
42. West A. R., Galloway M. P., Grace A. A., Regulation of striatal dopamine neurotransmission by nitric oxide: effector pathways and signaling mechanisms Synapse 2002 44 4 227 245 (Pubitemid 34496647)
43. Greengard P., The neurobiology of slow synaptic transmission Science 2001 294 5544 1024 1030 (Pubitemid 33041850)
44. Cenci M. A., Konradi C., Maladaptive striatal plasticity in l-DOPA-induced dyskinesia Progress in Brain Research 2010 183 C 209 233
45. Iravani M. M., Jenner P., Mechanisms underlying the onset and expression of levodopa-induced dyskinesia and their pharmacological manipulation Journal of Neural Transmission 2011 118 12 1661 1690
46. Lee J., Zhu W. M., Stanic D., Finkelstein D. I., Horne M. H., Henderson J., Lawrence A. J., O'Connor L., Tomas D., Drago J., Horne M. K., Sprouting of dopamine terminals and altered dopamine release and uptake in Parkinsonian dyskinaesia Brain 2008 131 6 1574 1587 (Pubitemid 351806467)
47. Calabresi P., Mercuri N. B., Sancesario G., Bernardi G., Electrophysiology of dopamine-denervated striatal neurons. Implications for Parkinson's disease Brain 1993 116 2 433 452 (Pubitemid 23104057)
48. Ingham C. A., Hood S. H., Taggart P., Arbuthnott G. W., Plasticity of synapses in the rat neostriatum after unilateral lesion of the nigrostriatal dopaminergic pathway Journal of Neuroscience 1998 18 12 4732 4743 (Pubitemid 28280181)
49. Lindefors N., Ungerstedt U., Bilateral regulation of glutamate tissue and extracellular levels in caudate-putamen by midbrain dopamine neurons Neuroscience Letters 1990 115 2-3 248 252 (Pubitemid 20231622)
50. Meshul C. K., Emre N., Nakamura C. M., Allen C., Donohue M. K., Buckman J. F., Time-dependent changes in striatal glutamate synapses following a 6-hydroxydopamine lesion Neuroscience 1999 88 1 1 16 (Pubitemid 28440387)
51. Picconi B., Centonze D., Rossi S., Bernardi G., Calabresi P., Therapeutic doses of L-dopa reverse hypersensitivity of corticostriatal D2-dopamine receptors and glutamatergic overactivity in experimental parkinsonism Brain 2004 127 7 1661 1669 (Pubitemid 38899418)
52. Abarca J., Gysling K., Roth R. H., Bustos G., Changes in extracellular levels of glutamate and aspartate in rat substantia nigra induced by dopamine receptor ligands: in vivo microdialysis studies Neurochemical Research 1995 20 2 159 169
53. Biggs C. S., Starr M. S., Dopamine and glutamate control each other's release in the basal ganglia: a microdialysis study of the entopeduncular nucleus and substantia nigra Neuroscience and Biobehavioral Reviews 1997 21 4 497 504 (Pubitemid 27255855)
54. Carta M., Carlsson T., Kirik D., Bjrklund A., Dopamine released from 5-HT terminals is the cause of L-DOPA-induced dyskinesia in parkinsonian rats Brain 2007 130 7 1819 1833 (Pubitemid 47343795)
55. Rylander D., Parent M., O-Sullivan S. S., Dovero S., Lees A. J., Bezard E., Descarries L., Cenci M. A., Maladaptive plasticity of serotonin axon terminals in levodopa-induced dyskinesia Annals of Neurology 2010 68 5 619 628
56. Chase T. N., Oh J. D., Striatal mechanisms and pathogenesis of parkinsonian signs and motor complications Annals of Neurology 2000 47 4 Supplement 1 S122 S129
57. Dunah A. W., Wang Y., Yasuda R. P., Kameyama K., Huganir R. L., Wolfe B. B., Standaert D. G., Alterations in subunit expression, composition, and phosphorylation of striatal N -methyl-D-aspartate glutamate receptors in a rat 6-hydroxydopamine model of Parkinson's disease Molecular Pharmacology 2000 57 2 342 352 (Pubitemid 30084511)
58. Santini E., Valjent E., Usiello A., Carta M., Borgkvist A., Girault J. A., Hervé D., Greengard P., Fisone G., Critical involvement of cAMP/DARPP-32 and extracellular signal-regulated protein kinase signaling in L-DOPA-induced dyskinesia Neuroscience 2007 27 26 6995 7005 (Pubitemid 47015907)
59. Pavn N., Martn A. B., Mendialdua A., Moratalla R., ERK phosphorylation and FosB expression are associated with L-DOPA-induced dyskinesia in hemiparkinsonian mice Biological Psychiatry 2006 59 1 64 74 (Pubitemid 43005237)
60. Westin J. E., Vercammen L., Strome E. M., Konradi C., Cenci M. A., Spatiotemporal pattern of striatal ERK1/2 phosphorylation in a rat model of L-DOPA-induced dyskinesia and the role of dopamine D1 receptors Biological Psychiatry 2007 62 7 800 810 (Pubitemid 47374647)
61. Feyder M., Bonito-Oliva A., Fisone G., L-dopa-induced dyskinesia and abnormal signalling in striatal medium spiny neurons: focus on dopamine D1 receptor-mediated transmission Frontiers in Behavioral Neuroscience 2011 5, article 71
62. Picconi B., Bagetta V., Ghiglieri V., Paill V., Di Filippo M., Pendolino V., Tozzi A., Giamp C., Fusco F. R., Sgobio C., Calabresi P., Inhibition of phosphodiesterases rescues striatal long-term depression and reduces levodopa-induced dyskinesia Brain 2011 134 2 375 387
63. Picconi B., Paillé V., Ghiglieri V., Bagetta V., Barone I., Lindgren H. S., Bernardi G., Angela Cenci M., Calabresi P., l-DOPA dosage is critically involved in dyskinesia via loss of synaptic depotentiation Neurobiology of Disease 2008 29 2 327 335
64. Cenci M. A., Dopamine dysregulation of movement control in l-DOPA-induced dyskinesia Trends in Neurosciences 2007 30 5 236 243 (Pubitemid 46654236)
65. Lundblad M., Picconi B., Lindgren H., Cenci M. A., A model of L-DOPA-induced dyskinesia in 6-hydroxydopamine lesioned mice: relation to motor and cellular parameters of nigrostriatal function Neurobiology of Disease 2004 16 1 110 123 (Pubitemid 38569802)
66. Gardoni F., Sgobio C., Pendolino V., Calabresi P., Di Luca M., Picconi B., Targeting NR2A-containingNMDA receptors reduces L-DOPA-induced dyskinesias. Neurobiology of Aging. In press
67. Giorgi M., D'Angelo V., Esposito Z., Nuccetelli V., Sorge R., Martorana A., Stefani A., Bernardi G., Sancesario G., Lowered cAMP and cGMP signalling in the brain during levodopa-induced dyskinesias in hemiparkinsonian rats: new aspects in the pathogenetic mechanisms European Journal of Neuroscience 2008 28 5 941 950
68. Errico F., Pirro M. T., Affuso A., Spinelli P., De Felice M., D'Aniello A., Di Lauro R., A physiological mechanism to regulate d-aspartic acid and NMDA levels in mammals revealed by d-aspartate oxidase deficient mice Gene 2006 374 1-2 50 57
69. Errico F., Bonito-Oliva A., Bagetta V., Higher free D-aspartate and N -methyl-D-aspartate levels prevent striatal depotentiation and anticipate L-DOPA-induced dyskinesia Experimental Neurology 2011 232 2 240 250
70. Santini E., Heiman M., Greengard P., Valjent E., Fisone G., Inhibition of mTOR signaling in parkinson's disease prevents L-DOPA-induced dyskinesia Science Signaling 2009 2 80 ra36
71. Subramaniam S., Napolitano F., Mealer R. G., Rhes, a striatal-enriched small G protein, mediates mTOR signalling and L-DOPA-induced dyskinesia Nature Neuroscience 2012 15 2 191 193
72. Hoeffer C. A., Klann E., mTOR signaling: at the crossroads of plasticity, memory and disease Trends in Neurosciences 2010 33 2 67 75
73. Ghiglieri V., Pendolino V., Bagetta V., Sgobio C., Calabresi P., Picconi B., mTOR inhibitor rapamycin suppresses striatal post-ischemic LTP Experimental Neurology 2010 226 2 328 331
74. Kannari K., Yamato H., Shen H., Tomiyama M., Suda T., Matsunaga M., Activation of 5-HT1A but not 5-HT1B receptors attenuates an increase in extracellular dopamine derived from exogenously administered L-DOPA in the striatum with nigrostriatal denervation Journal of Neurochemistry 2001 76 5 1346 1353 (Pubitemid 32198239)
75. Tanaka H., Kannari K., Maeda T., Tomiyama M., Suda T., Matsunaga M., Role of serotonergic neuron in L-DOPA-derived extracellular dopamine in the striatum of 6-OHDA-lesioned rats NeuroReport 1999 10 3 631 634 (Pubitemid 29333295)
76. Dupre K. B., Ostock C. Y., Eskow Jaunarajs K. L., Button T., Savage L. M., Wolf W., Bishop C., Local modulation of striatal glutamate efflux by serotonin 1A receptor stimulation in dyskinetic, hemiparkinsonian rats Experimental Neurology 2011 229 2 288 299
77. Huot P., Brotchie J. M., 5-HT(1A) receptor stimulation and L-DOPA-induced dyskinesia in Parkinson's disease: bridging the gap between serotonergic and glutamatergic mechanisms Nature Neuroscience 2011 231 2 195 198
78. Ostock C. Y., Dupre K. B., Eskow Jaunarajs K. L., Walters H., George J., Krolewski D., Walker P. D., Bishop C., Role of the primary motor cortex in l-DOPA-induced dyskinesia and its modulation by 5-HT1A receptor stimulation Neuropharmacology 2011 61 4 753 760
79. Andersson M., Hilbertson A., Cenci M. A., Striatal fosB expression is causally linked with L-DOPA-induced abnormal involuntary movements and the associated upregulation of striatal prodynorphin mRNA in a rat model of Parkinson's disease Neurobiology of Disease 1999 6 6 461 474 (Pubitemid 30036616)
80. Muoz A., Li Q., Gardoni F., Marcello E., Qin C., Carlsson T., Kirik D., Di Luca M., Bjrklund A., Bezard E., Carta M., Combined 5-HT1A and 5-HT1B receptor agonists for the treatment of L-DOPA-induced dyskinesia Brain 2008 131 12 3380 3394
81. Rylander D., The serotonin system: a potential target for anti-dyskinetic treatments and biomarker discovery Parkinsonism Related Disorders 2012 18 Supplement 1 S126 S128
82. Guillin O., Diaz J., Carroll P., Griffon N., Schwartz J. C., Sokoloff P., BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization Nature 2001 411 6833 86 89 (Pubitemid 32428194)
83. Samadi P., Morissette M., Lévesque D., Di Paolo T., BDNF levels are not related with levodopa-induced dyskinesias in MPTP monkeys Movement Disorders 2010 25 1 116 121
84. Potenza R. L., Tebano M. T., Martire A., Domenici M. R., Pepponi R., Armida M., Pzzola A., Minghetti L., Popoli P., Adenosine A2A receptors modulate BDNF both in normal conditions and in experimental models of Huntington's disease Purinergic Signalling 2007 3 4 333 338
85. Tebano M. T., Martire A., Chiodi V., Ferrante A., Popoli P., Role of adenosine A 2A receptors in modulating synaptic functions and brain levels of BDNF: a possible key mechanism in the pathophysiology of Huntington's disease TheScientificWorldJOURNAL 2010 10 1768 1782
86. Blandini F., Armentero M. T., New pharmacological avenues for the treatment of l-DOPA-induced dyskinesias in Parkinson's disease: targeting glutamate and adenosine receptors Expert Opinion on Investigational Drugs 2012 21 2 153 168
87. Tozzi A., Tscherter A., Belcastro V., Tantucci M., Costa C., Picconi B., Centonze D., Calabresi P., Borsini F., Interaction of A2A adenosine and D2 dopamine receptors modulates corticostriatal glutamatergic transmission Neuropharmacology 2007 53 6 783 789 (Pubitemid 47542336)
88. Kayadjanian N., Cortical and nigral deafferentation and striatal cholinergic markers in the rat dorsal striatum: different effects on the expression of mRNAs encoding choline acetyltransferase and muscarinic m1 and m4 receptors European Journal of Neuroscience 1999 11 10 3659 3668 (Pubitemid 29484262)
89. Ding J., Guzman J. N., Tkatch T., Chen S., Goldberg J. A., Ebert P. J., Levitt P., Wilson C. J., Hamm H. E., Surmeier D. J., RGS4-dependent attenuation of M4 autoreceptor function in striatal cholinergic interneurons following dopamine depletion Nature Neuroscience 2006 9 6 832 842
90. Bonsi P., Martella G., Cuomo D., Platania P., Sciamanna G., Bernardi G., Wess J., Pisani A., Loss of muscarinic autoreceptor function impairs long-term depression but not long-term potentiation in the striatum Neuroscience 2008 28 24 6258 6263
91. Ding Y., Won L., Britt J. P., Lim S. A. O., McGehee D. S., Kang U. J., Enhanced striatal cholinergic neuronal activity mediates L-DOPA-induced dyskinesia in parkinsonian mice Proceedings of the National Academy of Sciences of the United States of America 2011 108 2 840 845
92. Bateup H. S., Santini E., Shen W., Birnbaum S., Valjent E., Surmeier D. J., Fisone G., Nestler E. J., Greengard P., Distinct subclasses of medium spiny neurons differentially regulate striatal motor behaviors Proceedings of the National Academy of Sciences of the United States of America 2010 107 33 14845 14850
93. Belujon P., Lodge D. J., Grace A. A., Aberrant striatal plasticity is specifically associated with dyskinesia following levodopa treatment Movement Disorders 2010 25 11 1568 1576
94. Crittenden J. R., Graybiel A. M., Basal ganglia disorders associated with imbalances in the striatal striosome and matrix compartments Frontiers in Neuroanatomy 2011 5, article 59